| Model Number |
W4TR03 |
| Medical Device Problem Code |
Use of Device Problem (1670)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
12/06/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that the cardiac resynchronization therapy defibrillator (crt-d) was explanted and replaced due to being at normal elective replacement indicator (eri).The device subsequently tested out of specification during manufacturer's analysis.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Product event summary: the device was returned and analyzed.Analysis of the returned device was inconclusive.Analysis of the hybrid revealed this non-complaint device was returned with no information.The device failed the incoming longevity calculation at 75.11%.Review of save to disk data showed that there was a steeper than normal voltage drop throughout the life of the device while the device was still implanted.Both loaded and unloaded pacing current drain levels were normal for this device.There was no evidence of a high current drain condition on the hybrid.Analysis of the battery revealed review of the manufacturing data, the data gathered during the visual and dimensional inspection, and the electrical testing data, did not show any abnormal results.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the cardiac resynchronization therapy pacemaker (crt-p) was explanted and replaced due to being at normal elective replacement indicator (eri).The device subsequently tested out of specification during manufacturer's analysis.No patient complications have been reported as a result of this event.
|
| |
|
Search Alerts/Recalls
|